enroveto solution 200mg
v.m.d. nv, belgium - enrofloxacin - solution - 200mg
flutan solution 200 mg
tan veterina limited, tanzania - enrofloxacin - solution - 200 mg
enroveto 20 oral solution (vet.) 200 mg/ml oral solution
nuevo milenio, inc.; distributor: nuevo milenio, inc. - enrofloxacin - oral solution - 200 mg/ml
enroflox-200 200mg/ ml solution for injection (sc/im)
enrofloxacin (vet.) - solution for injection (sc/im) - 200mg/ ml
floxinor 200mg/ml oral liquid ordinary liquids
hebei hope harmony pharmaceutical co., ltd - enrofloxacin - oral liquid ordinary liquids - 200mg/ml
ashienro® - bh (200mg + 15mg) per ml oral liquid ordinary liquids
ashish life science pvt. ltd. - enrofloxacin + bromhexine hydrochloride - oral liquid ordinary liquids - (200mg + 15mg) per ml
quellaxcin- enrofloxacin injection, solution
aspen veterinary resources - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - indications: cattle - single-dose therapy: quellaxcin™ 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-day therapy: quellaxcin™ 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida andhistophilus somni in beef and non-lactating dairy cattle. swine: quellaxcin™ 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae . quellaxcin™ 100 is indicated for the control of colibacillosis in groups
enromed- enrofloxacin injection, solution
bimeda, inc. - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - indications: cattle - single-dose therapy: enromed™ 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida, histophilus somni and mycoplasma bovis in beef and non-lactating dairy cattle; and for the control of brd in beef and non-lactating dairy cattle at high risk of developing brd associated with m. haemolytica, p. multocida, h. somni and m. bovis. cattle - multiple-day therapy: enromed™ 100 is indicated for the treatment of bovine respiratory disease (brd) associated with mannheimia haemolytica, pasteurella multocida and histophilus somni in beef and non-lactating dairy cattle. swine: enromed™ 100 is indicated for the treatment and control of swine respiratory disease (srd) associated with actinobacillus pleuropneumoniae, pasteurella multocida, haemophilus parasuis, streptococcus suis, bordetella bronchiseptica and mycoplasma hyopneumoniae. enromed™ 100 is indicated for the control of colibacillosis in groups or pens of
baytril 100-ca1- enrofloxacin injection, solution
bayer healthcare, llc animal health division - enrofloxacin (unii: 3dx3xek1bn) (enrofloxacin - unii:3dx3xek1bn) - baytril® 100-ca1 is indicated for the treatment of clinical anaplasmosis associated with anaplasma marginale in replacement dairy heifers under 20 months of age and all classes of beef cattle except beef calves less than 2 months of age and beef bulls intended for breeding (any age). not for use in any other class of dairy cattle or in veal calves.
levoflok
universal farma s.l. - enrofloxacin 100 mg/ml - oral solution - chicken food, rabbit food - enrofloxacin